Literature DB >> 21191481

TNF-α and Microglial Hormetic Involvement in Neurological Health & Migraine.

Richard P Kraig1, Heidi M Mitchell, Barbara Christie-Pope, Phillip E Kunkler, David M White, Ya-Ping Tang, George Langan.   

Abstract

Environmental enrichment, i.e., increased intellectual, social, and physical activity makes brain more resilient to subsequent neurological disease. The mechanisms for this effect remain incompletely defined, but evidence shows tumor necrosis factor-alpha (TNF-α) is involved. TNF-α, at acutely high levels, possesses the intrinsic capacity to enhance injury associated with neurological disease. Conversely, the effect of TNF-α at low-levels is nutritive over time, consistent with physiological conditioning hormesis. Evidence shows that neural activity triggers low-level pro-inflammatory signaling involving TNF-α. This low-level TNF-α signaling alters gene expression, resulting in an enhanced resilience to disease. Brain-immune signaling may become maladaptive when increased activity is chronic without sufficient periods of reduced activity necessary for nutritive adaptation. Such tonically increased activity may explain, for example, the transformation of episodic to chronic migraine with related increased susceptibility to spreading depression, the most likely underlying cause of this malady. Thus, TNF-α, whose function is to alter gene expression, and its principal cellular source, microglia, seem powerfully positioned to orchestrate hormetic immune signaling that establishes the phenotype of neurological health and disease from brain activity.

Entities:  

Keywords:  cytokine; environmental enrichment; excitotoxicity; migraine; neuro-immune; spreading depression

Year:  2010        PMID: 21191481      PMCID: PMC2990060          DOI: 10.2203/dose-response.09-056.Kraig

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  108 in total

Review 1.  Hormesis: the dose-response revolution.

Authors:  Edward J Calabrese; Linda A Baldwin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

2.  Optical current source density analysis in hippocampal organotypic culture shows that spreading depression occurs with uniquely reversing currents.

Authors:  Phillip E Kunkler; Raymond E Hulse; Michael W Schmitt; Charles Nicholson; Richard P Kraig
Journal:  J Neurosci       Date:  2005-04-13       Impact factor: 6.167

Review 3.  Microglial senescence: does the brain's immune system have an expiration date?

Authors:  Wolfgang J Streit
Journal:  Trends Neurosci       Date:  2006-07-20       Impact factor: 13.837

4.  Synaptic scaling mediated by glial TNF-alpha.

Authors:  David Stellwagen; Robert C Malenka
Journal:  Nature       Date:  2006-03-19       Impact factor: 49.962

5.  Ischemic tolerance in the rat neocortex following hypothermic preconditioning.

Authors:  S Nishio; M Yunoki; Z F Chen; M J Anzivino; K S Lee
Journal:  J Neurosurg       Date:  2000-11       Impact factor: 5.115

Review 6.  Ischemic tolerance.

Authors:  Takaaki Kirino
Journal:  J Cereb Blood Flow Metab       Date:  2002-11       Impact factor: 6.200

7.  Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease.

Authors:  Suvi Rovio; Ingemar Kåreholt; Eeva-Liisa Helkala; Matti Viitanen; Bengt Winblad; Jaakko Tuomilehto; Hilkka Soininen; Aulikki Nissinen; Miia Kivipelto
Journal:  Lancet Neurol       Date:  2005-11       Impact factor: 44.182

Review 8.  Recovery from brain injury in animals: relative efficacy of environmental enrichment, physical exercise or formal training (1990-2002).

Authors:  Bruno Will; Rodrigue Galani; Christian Kelche; Mark R Rosenzweig
Journal:  Prog Neurobiol       Date:  2004-02       Impact factor: 11.685

Review 9.  Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior.

Authors:  Mark P Mattson; Sic L Chan; Wenzhen Duan
Journal:  Physiol Rev       Date:  2002-07       Impact factor: 37.312

Review 10.  Divergent roles for tumor necrosis factor-alpha in the brain.

Authors:  Krishnan Sriram; James P O'Callaghan
Journal:  J Neuroimmune Pharmacol       Date:  2007-03-31       Impact factor: 7.285

View more
  20 in total

1.  Hormetic signaling patterns.

Authors:  Reinhard Wetzker; Ignacio Rubio
Journal:  Dose Response       Date:  2011-10-14       Impact factor: 2.658

2.  Cold pre-conditioning neuroprotection depends on TNF-α and is enhanced by blockade of interleukin-11.

Authors:  Heidi M Mitchell; David M White; Miriam S Domowicz; Richard P Kraig
Journal:  J Neurochem       Date:  2010-12-01       Impact factor: 5.372

3.  Intranasally administered IGF-1 inhibits spreading depression in vivo.

Authors:  Yelena Y Grinberg; Lois A Zitzow; Richard P Kraig
Journal:  Brain Res       Date:  2017-09-23       Impact factor: 3.252

4.  Insulin-like growth factor-1 lowers spreading depression susceptibility and reduces oxidative stress.

Authors:  Yelena Y Grinberg; Wim van Drongelen; Richard P Kraig
Journal:  J Neurochem       Date:  2012-05-17       Impact factor: 5.372

5.  Immunomodulatory Effect of Toll-Like Receptor-3 Ligand Poly I:C on Cortical Spreading Depression.

Authors:  Amir Ghaemi; Azadeh Sajadian; Babak Khodaie; Ahmad Ali Lotfinia; Mahmoud Lotfinia; Afsaneh Aghabarari; Maryam Khaleghi Ghadiri; Sven Meuth; Ali Gorji
Journal:  Mol Neurobiol       Date:  2014-11-23       Impact factor: 5.590

6.  TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome.

Authors:  Ian A Myles; Erik D Anderson; Noah J Earland; Kol A Zarember; Inka Sastalla; Kelli W Williams; Portia Gough; Ian N Moore; Sundar Ganesan; Cedar J Fowler; Arian Laurence; Mary Garofalo; Douglas B Kuhns; Mark D Kieh; Arhum Saleem; Pamela A Welch; Dirk A Darnell; John I Gallin; Alexandra F Freeman; Steven M Holland; Sandip K Datta
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

Review 7.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

8.  What are exosomes and how can they be used in multiple sclerosis therapy?

Authors:  Aya D Pusic; Kae M Pusic; Richard P Kraig
Journal:  Expert Rev Neurother       Date:  2014-02-19       Impact factor: 4.618

9.  Insulin-like growth factor-1 abrogates microglial oxidative stress and TNF-α responses to spreading depression.

Authors:  Yelena Y Grinberg; Megan E Dibbern; Victoria A Levasseur; Richard P Kraig
Journal:  J Neurochem       Date:  2013-04-30       Impact factor: 5.372

10.  Spreading depression requires microglia and is decreased by their M2a polarization from environmental enrichment.

Authors:  Kae M Pusic; Aya D Pusic; Jordan Kemme; Richard P Kraig
Journal:  Glia       Date:  2014-04-10       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.